Bridget-Anne Kirwan Selected Research

Nifedipine (Adalat)

4/2010	Gender differences in cardiac remodeling and clinical outcomes in chronic stable angina pectoris (from the ACTION Trial).
1/2010	Correlates of coronary angiography in patients with stable angina and geographical differences in its utilisation: the ACTION experience.
3/2008	Quality management of a large randomized double-blind multi-centre trial: the ACTION experience.
11/2007	Diagnostic criteria and adjudication process both determine published event-rates: the ACTION trial experience.
8/2007	Predictive value of local and core laboratory echocardiographic assessment of cardiac function in patients with chronic stable angina: The ACTION study.
8/2007	Uric acid and other renal function parameters in patients with stable angina pectoris participating in the ACTION trial: impact of nifedipine GITS (gastro-intestinal therapeutic system) and relation to outcome.
7/2007	Resource utilization implications of treatment were able to be assessed from appropriately reported clinical trial data.
7/2007	Blood pressure reduction in stable angina by nifedipine was related to stroke and heart failure reduction but not to coronary interventions.
3/2007	The development of heart failure in patients with stable angina pectoris.
1/2007	Tracking coronary calcification and atherosclerotic lesions in patients with stable angina pectoris undergoing nifedipine therapy.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Bridget-Anne Kirwan Research Topics

Disease

14	Heart Failure 06/2021 - 03/2005
12	Stable Angina 05/2011 - 09/2004
6	COVID-19 01/2022 - 10/2020
6	Myocardial Infarction 07/2016 - 09/2004
6	Stroke (Strokes) 05/2011 - 03/2005
6	Coronary Disease (Coronary Heart Disease) 04/2010 - 09/2004
3	Critical Illness (Critically Ill) 01/2022 - 08/2021
3	Inflammation (Inflammations) 12/2021 - 03/2015
3	Iron Deficiencies 12/2020 - 12/2009
3	Coronary Artery Disease (Coronary Atherosclerosis) 01/2007 - 03/2005
2	Thrombosis (Thrombus) 12/2021 - 11/2021
2	Cardiovascular Diseases (Cardiovascular Disease) 07/2016 - 03/2007
2	Transient Ischemic Attack 07/2007 - 03/2005
1	Infections 01/2022
1	Milk Hypersensitivity (Milk Allergy) 01/2022
1	Hemorrhage 11/2021
1	Hyperlipoproteinemia Type II (Familial Hypercholesterolemia) 07/2016
1	Unstable Angina 07/2016
1	Ischemic Stroke 07/2016
1	Wounds and Injuries (Trauma) 03/2015
1	Cachexia 12/2011
1	Body Weight (Weight, Body) 12/2010
1	Anemia 12/2009
1	Renal Insufficiency (Renal Failure) 08/2007
1	Atherosclerotic Plaque (Atheroma) 01/2007
1	Skin Neoplasms (Skin Cancer) 02/2006
1	Asthenia 02/2006
1	Constipation 02/2006
1	Erectile Dysfunction 02/2006
1	Hypotension (Low Blood Pressure) 02/2006
1	Polyuria 02/2006
1	Neoplasms (Cancer) 02/2006
1	Muscle Cramp (Cramp) 02/2006
1	Melanoma (Melanoma, Malignant) 02/2006
1	Hypertension (High Blood Pressure) 03/2005
1	Angina Pectoris 09/2004

Drug/Important Bio-Agent (IBA)

14	Nifedipine (Adalat)FDA LinkGeneric 04/2010 - 09/2004
5	ferric carboxymaltoseIBA 06/2021 - 12/2009
4	Heparin (Liquaemin)FDA LinkGeneric 01/2022 - 10/2020
4	IronIBA 06/2021 - 12/2009
4	CalciumIBA 05/2011 - 09/2004
3	Transferrin (beta 2 Transferrin)IBA 12/2020 - 12/2009
3	Ferritins (Ferritin)IBA 12/2020 - 12/2009
3	DiureticsIBA 01/2018 - 07/2007
2	AnticoagulantsIBA 01/2022 - 11/2021
2	D-JNKI-1IBA 02/2017 - 03/2015
2	AlginatesIBA 03/2016 - 09/2015
2	HydrogelsIBA 03/2016 - 09/2015
2	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 05/2011 - 07/2007
2	Angiotensin Receptor AntagonistsIBA 05/2011 - 07/2007
2	LipidsIBA 05/2011 - 10/2005
2	CreatinineIBA 03/2007 - 10/2005
1	Proteins (Proteins, Gene)FDA Link 01/2022
1	OligosaccharidesIBA 01/2022
1	crizanlizumabIBA 12/2021
1	Biomarkers (Surrogate Marker)IBA 12/2021
1	P-SelectinIBA 12/2021
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 11/2021
1	apixabanIBA 11/2021
1	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 10/2020
1	Dexamethasone (Maxidex)FDA LinkGeneric 02/2017
1	Ophthalmic Solutions (Eye Drops)IBA 02/2017
1	omega-Chloroacetophenone (Mace)IBA 07/2016
1	mipomersenIBA 07/2016
1	Lipoproteins (Lipoprotein)IBA 07/2016
1	LDL CholesterolIBA 07/2016
1	Amino Acids FDA Link 03/2015
1	Peptides (Polypeptides)IBA 03/2015
1	Vitamin K FDA Link 05/2011
1	Hemoglobins (Hemoglobin)IBA 12/2009
1	Uric Acid (Urate)IBA 08/2007
1	Cardiac GlycosidesIBA 07/2007
1	Glucose (Dextrose)FDA LinkGeneric 03/2007
1	Blood Glucose (Blood Sugar)IBA 10/2005

Therapy/Procedure

9	Therapeutics 01/2022 - 01/2007
1	Critical Care (Surgical Intensive Care) 08/2021
1	Artificial Respiration (Mechanical Ventilation) 10/2020
1	Injections 03/2016
1	Percutaneous Coronary Intervention 05/2011
1	Orthopedic Procedures 07/2007